PortalPublikationenA randomized, double-blind, phase 2 study of erythropoietin ...

A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.

Standard

A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. / Sühs, Kurt-Wolfram; Hein, Katharina; Sättler, Muriel B; Görlitz, Anke; Ciupka, Christoph; Scholz, Kerstin; Käsmann-Kellner, Barbara; Papanagiotou, Panagiotis; Schäffler, Nina; Restemeyer, Cordula; Bittersohl, Diana; Hassenstein, Andrea; Seitz, Berthold; Reith, Wolfgang; Fassbender, Klaus; Hilgers, Reinhard; Heesen, Christoph; Bähr, Mathias; Diem, Ricarda.

in: ANN NEUROL, Jahrgang 72, Nr. 2, 2, 2012, S. 199-210.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Sühs, K-W, Hein, K, Sättler, MB, Görlitz, A, Ciupka, C, Scholz, K, Käsmann-Kellner, B, Papanagiotou, P, Schäffler, N, Restemeyer, C, Bittersohl, D, Hassenstein, A, Seitz, B, Reith, W, Fassbender, K, Hilgers, R, Heesen, C, Bähr, M & Diem, R 2012, 'A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.', ANN NEUROL, Jg. 72, Nr. 2, 2, S. 199-210. <http://www.ncbi.nlm.nih.gov/pubmed/22926853?dopt=Citation>

APA

Sühs, K-W., Hein, K., Sättler, M. B., Görlitz, A., Ciupka, C., Scholz, K., Käsmann-Kellner, B., Papanagiotou, P., Schäffler, N., Restemeyer, C., Bittersohl, D., Hassenstein, A., Seitz, B., Reith, W., Fassbender, K., Hilgers, R., Heesen, C., Bähr, M., & Diem, R. (2012). A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. ANN NEUROL, 72(2), 199-210. [2]. http://www.ncbi.nlm.nih.gov/pubmed/22926853?dopt=Citation

Vancouver

Sühs K-W, Hein K, Sättler MB, Görlitz A, Ciupka C, Scholz K et al. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. ANN NEUROL. 2012;72(2):199-210. 2.

Bibtex

@article{5f5e693ac3ce472f8bc2ed409b9e23d5,
title = "A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.",
abstract = "Based on findings in animal models of autoimmune optic nerve inflammation, we have assessed the safety and efficacy of erythropoietin in patients presenting with a first episode of optic neuritis.",
keywords = "Adult, Humans, Male, Female, Middle Aged, Young Adult, Treatment Outcome, Double-Blind Method, Magnetic Resonance Imaging, Anti-Inflammatory Agents/*therapeutic use, Erythropoietin/*therapeutic use, Evoked Potentials, Visual/drug effects, Methylprednisolone/therapeutic use, Optic Nerve/drug effects/pathology, Optic Neuritis/*drug therapy/pathology, Retina/drug effects/pathology, Tomography, Optical Coherence, Visual Acuity/drug effects, Visual Field Tests, Visual Fields/drug effects, Adult, Humans, Male, Female, Middle Aged, Young Adult, Treatment Outcome, Double-Blind Method, Magnetic Resonance Imaging, Anti-Inflammatory Agents/*therapeutic use, Erythropoietin/*therapeutic use, Evoked Potentials, Visual/drug effects, Methylprednisolone/therapeutic use, Optic Nerve/drug effects/pathology, Optic Neuritis/*drug therapy/pathology, Retina/drug effects/pathology, Tomography, Optical Coherence, Visual Acuity/drug effects, Visual Field Tests, Visual Fields/drug effects",
author = "Kurt-Wolfram S{\"u}hs and Katharina Hein and S{\"a}ttler, {Muriel B} and Anke G{\"o}rlitz and Christoph Ciupka and Kerstin Scholz and Barbara K{\"a}smann-Kellner and Panagiotis Papanagiotou and Nina Sch{\"a}ffler and Cordula Restemeyer and Diana Bittersohl and Andrea Hassenstein and Berthold Seitz and Wolfgang Reith and Klaus Fassbender and Reinhard Hilgers and Christoph Heesen and Mathias B{\"a}hr and Ricarda Diem",
year = "2012",
language = "English",
volume = "72",
pages = "199--210",
journal = "ANN NEUROL",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.

AU - Sühs, Kurt-Wolfram

AU - Hein, Katharina

AU - Sättler, Muriel B

AU - Görlitz, Anke

AU - Ciupka, Christoph

AU - Scholz, Kerstin

AU - Käsmann-Kellner, Barbara

AU - Papanagiotou, Panagiotis

AU - Schäffler, Nina

AU - Restemeyer, Cordula

AU - Bittersohl, Diana

AU - Hassenstein, Andrea

AU - Seitz, Berthold

AU - Reith, Wolfgang

AU - Fassbender, Klaus

AU - Hilgers, Reinhard

AU - Heesen, Christoph

AU - Bähr, Mathias

AU - Diem, Ricarda

PY - 2012

Y1 - 2012

N2 - Based on findings in animal models of autoimmune optic nerve inflammation, we have assessed the safety and efficacy of erythropoietin in patients presenting with a first episode of optic neuritis.

AB - Based on findings in animal models of autoimmune optic nerve inflammation, we have assessed the safety and efficacy of erythropoietin in patients presenting with a first episode of optic neuritis.

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Young Adult

KW - Treatment Outcome

KW - Double-Blind Method

KW - Magnetic Resonance Imaging

KW - Anti-Inflammatory Agents/therapeutic use

KW - Erythropoietin/therapeutic use

KW - Evoked Potentials, Visual/drug effects

KW - Methylprednisolone/therapeutic use

KW - Optic Nerve/drug effects/pathology

KW - Optic Neuritis/drug therapy/pathology

KW - Retina/drug effects/pathology

KW - Tomography, Optical Coherence

KW - Visual Acuity/drug effects

KW - Visual Field Tests

KW - Visual Fields/drug effects

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Young Adult

KW - Treatment Outcome

KW - Double-Blind Method

KW - Magnetic Resonance Imaging

KW - Anti-Inflammatory Agents/therapeutic use

KW - Erythropoietin/therapeutic use

KW - Evoked Potentials, Visual/drug effects

KW - Methylprednisolone/therapeutic use

KW - Optic Nerve/drug effects/pathology

KW - Optic Neuritis/drug therapy/pathology

KW - Retina/drug effects/pathology

KW - Tomography, Optical Coherence

KW - Visual Acuity/drug effects

KW - Visual Field Tests

KW - Visual Fields/drug effects

M3 - SCORING: Journal article

VL - 72

SP - 199

EP - 210

JO - ANN NEUROL

JF - ANN NEUROL

SN - 0364-5134

IS - 2

M1 - 2

ER -